Company & Sponsor Intelligence

Avid Radiopharmaceuticals

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials13

Recruiting0

Completed13

Countries2

Therapeutic footprint

alzheimersparkinsons

Indexed studies

NCT00857415Phase III Study of the Correlation Between Florbetapir F18 PET Imaging and Amyloid Pathology in the Brain
alzheimers · United StatesPHASE3

NCT03322462Tau Screening Study in Patients With Early Symptomatic AD
alzheimers · United StatesPHASE2

NCT00857532Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients
parkinsons · United StatesPHASE2

NCT02016560Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects
alzheimers · United StatesPHASE2, PHASE3

NCT01518374Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
alzheimers · United StatesPHASE2

NCT00857506Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)
alzheimers · United StatesPHASE2

NCT01703702Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
alzheimers · United StatesPHASE4

NCT00702143A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
alzheimers · United StatesPHASE2

NCT01662882A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
alzheimers · JapanPHASE2, PHASE3

NCT01565330A Study of Two Doses of 18F-AV-45 in Alzheimer's Disease and Healthy Volunteers
alzheimers · United StatesPHASE1

NCT01550549Evaluation of Web-based Training to Educate Physicians in the Methods of Interpreting Florbetapir-PET Scans
alzheimers · NA

NCT04468347Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
alzheimers · PHASE1

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →